Autoimmune Disease Diagnosis Market Growth Status, Regional Trends Forecast To 2028

According to Precision Business Insights (PBI), the latest report the global autoimmune disease diagnosis market is expected to be worth USD 4,376.3 million in 2021 and projected to grow at a 6.5% CAGR over 2022 to 2028. The autoimmune disease diagnosis market is primarily driven by a few key factors including the rising prevalence of autoimmune disease, patient awareness of rising healthcare concerns, an increase in healthcare expenditure, rising government initiatives, and an increase in automation technologies, which lead to higher sensitivity, faster and easier diagnosis test results and disease prevention.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/autoimmune-disease-diagnosis-market/

The Consumables & Assay Kits Segment is Dominating the Autoimmune Disease Diagnosis Market:
Basaed on the product type, Assay Kits and Consumables segment is expected to dominate the market over the forecast years owing to rise in number of testing procedures in developed and developing countries due to government initiatives for the early stage disease diagnosis and reimbursement policies for the disease diagnosis in developed and developing economies. Moreover, Market players are focus on the development of advanced test kits to expand their portfolio in the global market. For instance, in July 2022, KSL Beutner Laboratories kaunched indirect immunofluorescence (IIF) serum blood test in USA market that identifies the laminin 332, an antigen associated with the chronic, debilitating autoimmune disease mucous membrane pemphigoid (MMP)

North America Leads Autoimmune Disease Diagnosis Market:
North America is expected to hold a significant market share in the global Autoimmune Disease Diagnosis market and is projected to grow at a prominent growth rate over the forecast years owing to an increase in the prevalence of autoimmune diseases across USA and Canada coupled with rise in R&D for the development of advanced test kits by the market players in the region. Moreover, due to advanced healthcare infrastructure in Germany, France, UK, and other European countries coupled with rise in healthcare expenditure the Europe autoimmune disease diagnosis market expected to create lucrative opportunities over the forecast years.

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
Global Autoimmune Disease Diagnosis market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliances to improve market revenue share and gaining significant geographic presence across the region. For instance, In May 2022, Thermo Fisher Scientific (US) launched Phadia 2500+ Instrument in the USA for diagnosis of celiac disease, rheumatoid arthritis, autoimmune liver disease, and autoimmune thyroid disease among others.

Request sample report at: https://precisionbusinessinsights.com/request-sample?product_id=59263

The autoimmune disease diagnosis market is segmented based on product, test type, disease, end user and geography.
Based on the product, the market is segmented into the following:
• Consumables & Assay Kits
• Instruments

Based on the test type, the market is segmented into the following:
• Routine Laboratory Tests
• Inflammatory Markers
• Autoantibodies & Immunologic Test
• Other Tests

Based on the disease, the market is segmented into the following:
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Sjögren's Syndrome
• Thyroiditis
• Scleroderma
• Other Diseases

Based on the end user, the market is segmented into the following:
• Clinical Laboratories
• Hospitals
• Other End Users

Based on Geography, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=59263

Key player's profiles in the autoimmune disease diagnosis market report are Thermo Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), Hycor Biomedical (US), Euroimmun Ag (Germany).

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.